Your session is about to expire
← Back to Search
Low SAR MRI Scans for Coronary Heart Disease
Study Summary
This trial is testing a new, lower-energy MRI scanner to see if it creates better pictures than a conventional MRI. The trial is for people with disease and healthy volunteers, ages 18 and older.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not been exposed to a specific contrast agent if my kidney function is below a certain level.I am 18 years old or older.I have a known heart condition.I do not have any known brain conditions or injuries.I do not have recent severe heart issues, uncontrolled asthma, or severe lung problems.I refuse to take medication to open my airways.My heart device is safe for MRI, and it was implanted at least 4 weeks ago.I have had less than three MRI scans with contrast in the last year.I am breastfeeding but can discard milk for 24 hours and avoid gadolinium exposure.I have severe COPD and need multiple medications or constant oxygen.I am not allergic to intravenous iron, ferumoxytol, or mannitol, and I am not breastfeeding or willing to stop for 24 hours.I consider myself currently healthy.I have a known musculoskeletal condition such as persistent neck pain, spinal issues, or knee disorders.I have a known abdominal condition like Crohn's disease or liver issues.I have a known lung condition other than heart-related issues.I use bronchodilators regularly or have had lung function tests with them.
- Group 1: Group B
- Group 2: Group C
- Group 3: Group A
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the greatest number of participants in this research endeavor?
"Affirmative. According to data posted on clinicaltrials.gov, the trial is actively recruiting patients who meet its inclusion criteria. This medical study was inaugurated on May 1st 2018 and has since been updated as recently as November 19th 2022; 2100 individuals are needed from one site for successful completion of this trial."
Is the research team currently enlisting participants for this experiment?
"Confirmed. According to the information provided on clinicaltrials.gov, this trial is currently in the process of seeking out potential candidates. It was first posted on May 1st 2018 and has been recently updated as of November 19th 2022; it is looking for 2100 participants across one single location."
Share this study with friends
Copy Link
Messenger